An Evaluation of the WHO QUAlityRights Program

Study acronym: EQUAR
StatusActive, Not Recruiting
PhaseNot applicable
SponsorGCS-CCOMS
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 1 of 13 entries
  2. Eligibility criteria expanded, about 7 words
    • Site details revised at 1 of 10 sites
    • Collaborators revised (2)
    • Study description expanded, about 5 words
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 10 of 10 sites
    v3
  4. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 10 of 10 sites
    v2
  5. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
GCS-CCOMS
2 trials monitored
See all monitored trials
The World Health Organization's (WHO) QualityRights (QR) program offers assessments and recommendations to help mental health facilities, on a voluntary basis, improve their care practices towards better respect of the rights of service users. The aim of this study is to evaluate the QR program in a French national context. The main questions it aims to answer are: * Does the QR program improve perceived satisfaction with care among mental health service users? * What are the implementation procedures of the program? * What is its budgetary impact? Researchers will compare the QR program intervention with usual practices.
Trial Details
NCT Number NCT06874439
Lead Sponsor GCS-CCOMS
Collaborators: INSERM ECEVE 1123, Assistance Publique - Hôpitaux de Paris
Conditions
(from sponsor)		 Recovery, Organization of Health Service, Mental Health Care, Mental Health Services
Enrollment 1,800 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov